Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center

Real‐world use of emicizumab in Chinese children with hemophilia A: Retrospective data from a comprehensive care center

ABSTRACT Importance Emicizumab (EMI) is efficacious and safe for hemophilia A (HA) prophylaxis. However, its high cost poses a challenge in China. Objective To explore the possibility of using reduced‐dosage EMI in Chinese HA children. Methods We conducted a retrospective study for HA children in ou...

Full description

Saved in:
Bibliographic Details
Main Authors: Qianqian Mao, Zhenping Chen, Guoqing Liu, Gang Li, Yingzi Zhen, Xiaoling Cheng, Zekun Li, Wanru Yao, Di Ai, Zhengping Li, Nan Wang, Man‐Chiu Poon, Runhui Wu
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Pediatric Investigation
Subjects:
Hemophilia A
Emicizumab
Prophylaxis
Online Access:https://doi.org/10.1002/ped4.12439
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ped4.12439

Similar Items